Loading...

Judge Affirms Opioid Judgment Against Major Pharmacy Chains

March 8, 2022 by Tom Ramstack
Lynn Wencus, of Wrentham, Mass., holds a poster, with a likeness of her son Jeff, at her home, in Wrentham, Wednesday, March 2, 2022. Wencus lost her son to a heroin overdose in 2017. (AP Photo/Steven Senne)

TRUMBULL COUNTY, Ohio — An Ohio federal judge overseeing a class action lawsuit over the opioid crisis on Monday refused to overturn a jury verdict that held major pharmacy chains liable for contributing to the addictions and overdoses blamed for killing nearly half a million Americans since 1999.

The ruling means CVS, Walgreens and Walmart are potentially liable for billions of dollars in legal claims.

The pharmacies argued they complied with all laws on dispensing the drugs. The plaintiffs accused the pharmacies of failing to properly investigate dangers of opioids before giving them to their customers.

The judge ruled the jury’s verdict in favor of the plaintiffs was supported by the evidence, meaning it can stand.

The class action lawsuit was filed by officials from two counties in Ohio on behalf of their residents who suffered the ill effects of opioids. They claimed the pharmacies’ failure to protect patients from opioids created a public nuisance.

Lake and Trumbull counties are asking the judge for $1 billion each from the pharmacies to help in treatment or compensation for their residents. A separate hearing is pending to determine the amount of damages.

Equally important, the judgment is the first in the nation to hold pharmacies liable for the opioid crisis. Other cases against opioid distributors are pending in New York and Washington state.

Attorneys for the pharmacies said Lake and Trumbull counties needed to demonstrate pharmacists dispensed illegitimate prescriptions to specific patients to prove their case.

U.S. District Judge Dan Polster disagreed, saying the counties offered adequate aggregate evidence the pharmacies dispensed dangerous opioids without taking proper precautions.

“In particular, plaintiffs presented evidence of defendants’ dispensing of large quantities of highly addictive drugs in the counties while repeatedly failing to take legally required, effective measures to identify and resolve ‘red flags’ prior to dispensing, and failing to document any due diligence with respect to those red flags,” the judge’s ruling said.

Attorneys for the Lake and Trumbull counties issued a statement saying they agreed with the judge’s ruling and added, “At this point, we are solely focused on making sure the people of Lake and Trumbull counties receive the necessary resources to support recovery efforts in their communities.”

Opioids are a broad category of powerful, addictive and inexpensive painkillers that entered the market in the 1990s. They typically are sold under the names OxyContin, Percocet, Vicodin and fentanyl.

Initially hailed as a breakthrough to help pain sufferers return to normal lives, their addictive and dangerous tendencies became obvious within a few years.

In 2010, the U.S. government began a crackdown on pharmacists and doctors who over-prescribed opioids.

An unintended result was that addicted patients who no longer had access to opiates turned to heroin as a substitute. A 2017 survey of Utah heroin addicts showed 80% started with prescription drugs.

An advisory on the website for the Centers for Disease Control and Prevention says, “From 1999–2019, nearly 500,000 people died from an overdose involving any opioid, including prescription and illicit opioids. This rise in opioid overdose deaths can be outlined in three distinct waves.

  1. The first wave began with increased prescribing of opioids in the 1990s, with overdose deaths involving prescription opioids (natural and semi-synthetic opioids and methadone) increasing since at least 1993.
  2. The second wave began in 2010, with rapid increases in overdose deaths involving heroin.
  3. The third wave began in 2013, with significant increases in overdose deaths involving synthetic opioids, particularly those involving illicitly manufactured fentanyl. The market for illicitly manufactured fentanyl continues to change, and it can be found in combination with heroin, counterfeit pills, and cocaine.”

Tom can be reached at tom@thewellnews.com

In The News

Health

Voting

Prescription Drugs

April 27, 2022
by Tom Ramstack
Lawmakers Say Consulting Firm Marketing Contributed to Half-Million Opioid Deaths

WASHINGTON — A congressional panel cast suspicions on a global business consulting firm Wednesday as a potential villain in the... Read More

WASHINGTON — A congressional panel cast suspicions on a global business consulting firm Wednesday as a potential villain in the opioid epidemic that has killed more than a half-million Americans. A McKinsey & Co. official admitted to earning at least $86 million for helping pharmaceutical companies... Read More

April 19, 2022
by Dan McCue
Supreme Court Seeks Solicitor General Input on Biologic Drug Patents

WASHINGTON — The U.S. Supreme Court on Monday asked Solicitor General Elizabeth Prelogar to weigh in on a drug patent... Read More

WASHINGTON — The U.S. Supreme Court on Monday asked Solicitor General Elizabeth Prelogar to weigh in on a drug patent case the outcome of which could ultimately be worth billions of dollars. The case, Amgen v. Sanofi, emanates from the U.S. District Court for the Federal... Read More

House Passes $35-a-Month Insulin Cap as Dems Seek Wider Bill

WASHINGTON (AP) — The House has passed a bill capping the monthly cost of insulin at $35 for insured patients,... Read More

WASHINGTON (AP) — The House has passed a bill capping the monthly cost of insulin at $35 for insured patients, part of an election-year push by Democrats for price curbs on prescription drugs at a time of rising inflation. Experts say the legislation, which passed 232-193... Read More

March 30, 2022
by Dan McCue
House to Vote on Insulin Price Reduction Bill Thursday

WASHINGTON — The House on Thursday is expected to vote to cap the out-of-pocket cost of insulin for consumers at... Read More

WASHINGTON — The House on Thursday is expected to vote to cap the out-of-pocket cost of insulin for consumers at $35 per month. If also passed by the Senate, which is expected to vote the measure up by Easter, the long-awaited reform will go into effect... Read More

March 19, 2022
by TWN
Congressional Panel Takes Deep Dive Into Future of FDA’s Accelerated Approvals

WASHINGTON — The House Energy and Commerce Subcommittee on Health panel Thursday spent the majority of their time considering the... Read More

WASHINGTON — The House Energy and Commerce Subcommittee on Health panel Thursday spent the majority of their time considering the future of the Food and Drug Administration's so-called Accelerated Approval Program. A number of the 20 different health care-related bills discussed by the subcommittee figure in... Read More

March 19, 2022
by TWN
CMS Decision to Limit Coverage of Alzheimer’s Treatment Takes Center Stage

WASHINGTON — A House panel scheduled to kick the tires on roughly 20 different health care-related bills on Thursday spent... Read More

WASHINGTON — A House panel scheduled to kick the tires on roughly 20 different health care-related bills on Thursday spent time considering the Food and Drug Administration’s decision to grant accelerated approval to the first disease-modifying treatment for Alzheimer’s disease and the Centers for Medicare and... Read More

News From The Well